Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues — Bart Degrève (1999) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues
Shared by
De Clercq Erik
KU Leuven
Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues
Article
1999
en
Authors
BD
Bart Degrève
De Clercq Erik
KU Leuven
JB
Jan Balzarini
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1987
Targets for the Antiviral Activity of Pyrimidine and Purine Nucleoside Analogues
De Clercq Erik
Article
1999
Budding Yeast as a Screening Tool for Discovery of Nucleoside Analogs for Use in HSV-1 TK Suicide-Gene Therapy
Stefaan Wera
,
Bart Degrève
,
Jan Balzarini
,
De Clercq Erik
,
Johan M. Thevelein
,
Johan Neyts
Article
1991
Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK− HSV-1 keratitis in rabbits
P. C. Maudgal
,
De Clercq Erik
Article
1997
Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer
Bart Degrève
,
Graciela Andreï
,
Manuel Izquierdo
,
J Piette
,
Kevin W. Morin
,
EE Knaus
,
LI Wiebe
,
I Basrah
,
RT Walker
,
De Clercq Erik
,
Jan Balzarini
Article
2003
Characterization of varicella-zoster virus (VZV) mutants resistant to bicyclic pyrimidine nucleoside analogues (BCNAs)
Graciela Andreï
,
Ghislain Opdenakker
,
Jan Balzarini
,
De Clercq Erik
,
Christopher McGuigan
,
Robert Snoeck
Discussion(0)
No comments yet. Be the first to comment.